Journal:
:international journal of hematology-oncology and stem cell research
0
thomas büchner university hospital, dept. of medicine, hematology and oncology, albert-
schweitzer-str. 33, d-48129 münster
wolfgang hiddemann university hospital, dept. of medicine, hematology and oncology, albert-
schweitzer-str. 33, d-48129 münster
wolfgang e berdel university hospital, dept. of medicine, hematology and oncology, albert-
schweitzer-str. 33, d-48129 münster
bernhard wörmann university hospital, dept. of medicine, hematology and oncology, albert-
schweitzer-str. 33, d-48129 münster
helmut löffler university hospital, dept. of medicine, hematology and oncology, albert-
schweitzer-str. 33, d-48129 münster
claudia schoch university hospital, dept. of medicine, hematology and oncology, albert-
schweitzer-str. 33, d-48129 münster
maintenance treatment for patients with acute myeloid leukemia (aml) in remission has recently been controversially discussed and even abandoned by several groups. an analysis of 16 published multicenter trials, however, revealed the highest probabilities of relapse free survival (rfs) in the range of 35-42 % at 4-5 years only in patients assigned to maintenance treatment when adult age and int...